ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
standalone
|
608 |
296K |
0 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
608
|
296K
|
0
|
|
ASX - By Stock
|
PPL |
Re:
Ann: Q4 FY24 Results Update Notice & Investor Briefing Invitation
|
|
standalone
|
6 |
2.6K |
3 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
6
|
2.6K
|
3
|
|
ASX - By Stock
|
PPL |
Re:
Ann: Q4 FY24 Results Update Notice & Investor Briefing Invitation
|
|
standalone
|
6 |
2.6K |
0 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
6
|
2.6K
|
0
|
|
ASX - By Stock
|
PPL |
Re:
Ann: Q4 FY24 Results Update Notice & Investor Briefing Invitation
|
|
standalone
|
6 |
2.6K |
0 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
6
|
2.6K
|
0
|
|
ASX - By Stock
|
KPO |
Re:
Ann: Regulatory & Project Development Update
|
|
standalone
|
210 |
64K |
0 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
210
|
64K
|
0
|
|
ASX - By Stock
|
RIM |
Re:
Ann: Successful Placement
|
|
standalone
|
61 |
33K |
2 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
61
|
33K
|
2
|
|
ASX - By Stock
|
KPO |
Re:
Ann: Regulatory & Project Development Update
|
|
standalone
|
210 |
64K |
1 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
210
|
64K
|
1
|
|
ASX - By Stock
|
KPO |
Re:
Ann: Regulatory & Project Development Update
|
|
standalone
|
210 |
64K |
0 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
210
|
64K
|
0
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
standalone
|
231 |
117K |
9 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
231
|
117K
|
9
|
|
ASX - By Stock
|
KPO Energy |
Re:
Current Status
|
|
standalone
|
12 |
5.1K |
1 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
12
|
5.1K
|
1
|
|
ASX - By Stock
|
PPL |
Re:
Ann: Final Director's Interest Notice - LJ
|
|
standalone
|
2 |
711 |
4 |
25/06/24 |
25/06/24 |
ASX - By Stock
|
2
|
711
|
4
|
|
ASX - By Stock
|
PPL |
Re:
Ann: Final Director's Interest Notice - LJ
|
|
standalone
|
2 |
711 |
5 |
25/06/24 |
25/06/24 |
ASX - By Stock
|
2
|
711
|
5
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
standalone
|
608 |
296K |
7 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
608
|
296K
|
7
|
|
ASX - By Stock
|
KPO |
Re:
Ann: Regulatory & Project Development Update
|
|
standalone
|
210 |
64K |
1 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
210
|
64K
|
1
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
standalone
|
231 |
117K |
12 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
231
|
117K
|
12
|
|
ASX - By Stock
|
KPO |
Re:
Ann: Regulatory & Project Development Update
|
|
standalone
|
210 |
64K |
1 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
210
|
64K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
PYC Filed Another Patent
|
|
standalone
|
36 |
25K |
14 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
36
|
25K
|
14
|
|
ASX - By Stock
|
KPO |
Re:
Ann: Notification of cessation of securities - KPO
|
|
standalone
|
1 |
642 |
0 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
1
|
642
|
0
|
|
ASX - By Stock
|
PYC |
Re:
Ann: PMS Drug Candidate Effective In Human Brain Cells
|
|
standalone
|
30 |
10K |
0 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
30
|
10K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
Ann: PMS Drug Candidate Effective In Human Brain Cells
|
|
standalone
|
30 |
10K |
6 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
30
|
10K
|
6
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Successful GLP Tox Studies in Second Blinding Eye Disease
|
|
standalone
|
21 |
9.8K |
3 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
21
|
9.8K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
standalone
|
608 |
296K |
7 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
608
|
296K
|
7
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
standalone
|
608 |
296K |
0 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
608
|
296K
|
0
|
|
ASX - By Stock
|
PPL |
Re:
Ann: Director Changes Update
|
|
standalone
|
3 |
1.3K |
7 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
3
|
1.3K
|
7
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
standalone
|
608 |
296K |
2 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
608
|
296K
|
2
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
standalone
|
608 |
296K |
10 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
608
|
296K
|
10
|
|
ASX - By Stock
|
ALA |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
standalone
|
3 |
2.6K |
0 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
3
|
2.6K
|
0
|
|
ASX - By Stock
|
KPO |
Re:
Ann: Regulatory & Project Development Update
|
|
standalone
|
210 |
64K |
0 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
210
|
64K
|
0
|
|
ASX - By Stock
|
KPO |
Re:
Ann: Regulatory & Project Development Update
|
|
standalone
|
210 |
64K |
0 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
210
|
64K
|
0
|
|
ASX - By Stock
|
SI6 |
Re:
Ann: Board Change
|
|
standalone
|
10 |
3.1K |
3 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
10
|
3.1K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Successful GLP Tox Studies in Second Blinding Eye Disease
|
|
standalone
|
21 |
9.8K |
0 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
21
|
9.8K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
standalone
|
608 |
296K |
2 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
608
|
296K
|
2
|
|
ASX - By Stock
|
KPO |
Re:
Ann: Appointment of Matthew Jenkins as Non Executive Director
|
|
standalone
|
1 |
648 |
3 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
1
|
648
|
3
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
standalone
|
231 |
117K |
0 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
231
|
117K
|
0
|
|
ASX - By Stock
|
KPO |
Re:
Ann: Non-Renounceable Entitlement Offer Results
|
|
standalone
|
7 |
2.0K |
1 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
7
|
2.0K
|
1
|
|
ASX - By Stock
|
KPO |
Re:
Ann: Non-Renounceable Entitlement Offer Results
|
|
standalone
|
7 |
2.0K |
1 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
7
|
2.0K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Kidney Disease Drug Candidate Progressing to Human Trials
|
|
standalone
|
32 |
14K |
1 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
32
|
14K
|
1
|
|
ASX - By Stock
|
PPL Technology |
Re:
A message to the Board of Directors
|
|
standalone
|
12 |
6.3K |
2 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
12
|
6.3K
|
2
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Kidney Disease Drug Candidate Progressing to Human Trials
|
|
standalone
|
32 |
14K |
0 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
32
|
14K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
standalone
|
608 |
296K |
1 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
608
|
296K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
standalone
|
608 |
296K |
0 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
608
|
296K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
standalone
|
608 |
296K |
2 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
608
|
296K
|
2
|
|
ASX - By Stock
|
PYC |
Re:
PYC Filed Another Patent
|
|
standalone
|
36 |
25K |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
36
|
25K
|
1
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
standalone
|
231 |
117K |
8 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
231
|
117K
|
8
|
|
ASX - By Stock
|
KPO |
Re:
Ann: Clarification Announcement
|
|
standalone
|
2 |
1.1K |
1 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
2
|
1.1K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
PYC Filed Another Patent
|
|
standalone
|
36 |
25K |
10 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
36
|
25K
|
10
|
|
ASX - By Stock
|
PYC |
Re:
PYC Filed Another Patent
|
|
standalone
|
36 |
25K |
3 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
36
|
25K
|
3
|
|
ASX - By Stock
|
PPL |
Re:
Ann: H1 FY24 Results Presentation
|
|
standalone
|
15 |
6.5K |
4 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
15
|
6.5K
|
4
|
|
ASX - By Stock
|
PPL |
Re:
Ann: H1 FY24 Results Presentation
|
|
standalone
|
15 |
6.5K |
3 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
15
|
6.5K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
Ann: PYC Equity Raising to Raise up to $74.6 Million
|
|
standalone
|
19 |
10K |
3 |
16/03/24 |
16/03/24 |
ASX - By Stock
|
19
|
10K
|
3
|
|